Sarilumab Efficacy and Safety in Adults With Early Polymyalgia Rheumatica

NCT07286214 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

300

Enrollment

INDUSTRY

Sponsor class

Conditions

Polymyalgia Rheumatica

Interventions

DRUG: Sarilumab
DRUG: Sarilumab
DRUG: Placebo

Sponsor

Sanofi

Collaborators

[object Object]